000 01557 a2200421 4500
005 20250515175509.0
264 0 _c20090813
008 200908s 0 0 eng d
022 _a1524-4563
024 7 _a10.1161/HYPERTENSIONAHA.109.129171
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEllison, David H
245 0 0 _aThiazide effects and adverse effects: insights from molecular genetics.
_h[electronic resource]
260 _bHypertension (Dallas, Tex. : 1979)
_cAug 2009
300 _a196-202 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review
650 0 4 _aAnimals
650 0 4 _aBlood Pressure Determination
650 0 4 _aFemale
650 0 4 _aGlomerular Filtration Rate
650 0 4 _aHumans
650 0 4 _aHyperglycemia
_xchemically induced
650 0 4 _aHypertension
_xdrug therapy
650 0 4 _aHypokalemia
_xchemically induced
650 0 4 _aKidney Diseases
_xchemically induced
650 0 4 _aMale
650 0 4 _aMolecular Biology
650 0 4 _aPrognosis
650 0 4 _aRats
650 0 4 _aRisk Assessment
650 0 4 _aSensitivity and Specificity
650 0 4 _aSeverity of Illness Index
650 0 4 _aThiazides
_xadverse effects
650 0 4 _aTreatment Outcome
700 1 _aLoffing, Johannes
773 0 _tHypertension (Dallas, Tex. : 1979)
_gvol. 54
_gno. 2
_gp. 196-202
856 4 0 _uhttps://doi.org/10.1161/HYPERTENSIONAHA.109.129171
_zAvailable from publisher's website
999 _c18981480
_d18981480